• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者脑脊液中tau蛋白水平升高。

Increased cerebrospinal fluid tau in patients with Alzheimer's disease.

作者信息

Jensen M, Basun H, Lannfelt L

机构信息

Karolinska Institute, Department of Clinical Neuroscience, Huddinge University Hospital, Sweden.

出版信息

Neurosci Lett. 1995 Feb 17;186(2-3):189-91. doi: 10.1016/0304-3940(95)11297-a.

DOI:10.1016/0304-3940(95)11297-a
PMID:7777193
Abstract

One of the pathological features in Alzheimer's disease (AD) is neurofibrillary tangles in the brain. The main constituent of tangles is the microtubuli-associated protein tau in a hyperphosphorylated state. Tau is also released into cerebrospinal fluid (CSF), and in this study we have used an enzyme linked immunosorbent assay to measure tau in CSF from AD and control cases. Our findings show that tau levels in AD cases are significantly elevated compared to healthy control individuals. We suggest that tau may serve as a biochemical marker of Alzheimer's disease.

摘要

阿尔茨海默病(AD)的病理特征之一是大脑中的神经原纤维缠结。缠结的主要成分是处于高度磷酸化状态的微管相关蛋白tau。Tau蛋白也会释放到脑脊液(CSF)中,在本研究中,我们使用酶联免疫吸附测定法来测量AD患者和对照者脑脊液中的tau蛋白。我们的研究结果表明,与健康对照个体相比,AD患者的tau蛋白水平显著升高。我们认为tau蛋白可能作为阿尔茨海默病的生化标志物。

相似文献

1
Increased cerebrospinal fluid tau in patients with Alzheimer's disease.阿尔茨海默病患者脑脊液中tau蛋白水平升高。
Neurosci Lett. 1995 Feb 17;186(2-3):189-91. doi: 10.1016/0304-3940(95)11297-a.
2
Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.脑脊液β淀粉样蛋白42和tau蛋白作为大脑中阿尔茨海默病型病理变化的生物标志物。
Arch Neurol. 2009 Mar;66(3):382-9. doi: 10.1001/archneurol.2008.596.
3
Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease.阿尔茨海默病患者脑脊液中β-淀粉样蛋白1-42水平降低,tau蛋白水平升高。
JAMA. 2003;289(16):2094-103. doi: 10.1001/jama.289.16.2094.
4
Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.阿尔茨海默病风险对照受试者的脑脊液β淀粉样蛋白1-42和tau蛋白:APOE ε4等位基因的影响
Biol Psychiatry. 2004 Nov 1;56(9):670-6. doi: 10.1016/j.biopsych.2004.07.021.
5
Cerebrospinal fluid markers for Alzheimer's disease in a cognitively healthy cohort of young and old adults.认知健康的青年和老年人群中阿尔茨海默病的脑脊液标志物。
Alzheimers Dement. 2012 Nov;8(6):520-7. doi: 10.1016/j.jalz.2011.10.003. Epub 2012 Jun 6.
6
Proteomic analysis of cerebrospinal fluid in Alzheimer's disease: wanted dead or alive.阿尔茨海默病脑脊液的蛋白质组学分析:死活不论
J Alzheimers Dis. 2015;44(4):1303-12. doi: 10.3233/JAD-140141.
7
Increased cerebrospinal fluid levels of double-stranded RNA-dependant protein kinase in Alzheimer's disease.阿尔茨海默病患者脑脊液中双链 RNA 依赖性蛋白激酶水平升高。
Biol Psychiatry. 2012 May 1;71(9):829-35. doi: 10.1016/j.biopsych.2011.11.031. Epub 2012 Jan 26.
8
Comprehensive Quantitative Profiling of Tau and Phosphorylated Tau Peptides in Cerebrospinal Fluid by Mass Spectrometry Provides New Biomarker Candidates.通过质谱法对脑脊液中的 Tau 蛋白和磷酸化 Tau 肽进行综合定量分析可提供新的生物标志物候选物。
J Alzheimers Dis. 2017;55(1):303-313. doi: 10.3233/JAD-160633.
9
Validation of a prototype tau Thr231 phosphorylation CSF ELISA as a potential biomarker for Alzheimer's disease.验证 Tau Thr231 磷酸化 CSF ELISA 原型作为阿尔茨海默病潜在生物标志物的研究。
J Neural Transm (Vienna). 2019 Mar;126(3):339-348. doi: 10.1007/s00702-019-01982-5. Epub 2019 Feb 14.
10
Alzheimer's Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate.阿尔茨海默病相关脑脊液生物标志物与脑脊液容量或脑脊液生成率无关。
J Alzheimers Dis. 2017;58(3):821-828. doi: 10.3233/JAD-161257.

引用本文的文献

1
Risk of Alzheimer's Disease and Related Dementias in Persons with Glaucoma: A National Cohort Study.青光眼患者罹患阿尔茨海默病及相关痴呆症的风险:一项全国性队列研究。
Ophthalmology. 2024 Mar;131(3):302-309. doi: 10.1016/j.ophtha.2023.10.014. Epub 2023 Oct 13.
2
Tau: a biomarker of Huntington's disease.tau:亨廷顿病的生物标志物。
Mol Psychiatry. 2023 Oct;28(10):4070-4083. doi: 10.1038/s41380-023-02230-9. Epub 2023 Sep 25.
3
Ultrastructural and biochemical classification of pathogenic tau, α-synuclein and TDP-43.致病tau、α-突触核蛋白和 TDP-43 的超微结构和生化分类。
Acta Neuropathol. 2022 Jun;143(6):613-640. doi: 10.1007/s00401-022-02426-3. Epub 2022 May 5.
4
Targeting tau only extracellularly is likely to be less efficacious than targeting it both intra- and extracellularly.靶向 tau 仅细胞外可能不如靶向细胞内外都更有效。
Semin Cell Dev Biol. 2022 Jun;126:125-137. doi: 10.1016/j.semcdb.2021.12.002. Epub 2021 Dec 9.
5
Vitamin K2 Modulates Organelle Damage and Tauopathy Induced by Streptozotocin and Menadione in SH-SY5Y Cells.维生素K2调节链脲佐菌素和甲萘醌在SH-SY5Y细胞中诱导的细胞器损伤和tau蛋白病。
Antioxidants (Basel). 2021 Jun 20;10(6):983. doi: 10.3390/antiox10060983.
6
Challenges and Advances in Antemortem Diagnosis of Human Transmissible Spongiform Encephalopathies.人类可传播性海绵状脑病生前诊断的挑战与进展
Front Bioeng Biotechnol. 2020 Oct 20;8:585896. doi: 10.3389/fbioe.2020.585896. eCollection 2020.
7
Role of Body-Fluid Biomarkers in Alzheimer's Disease Diagnosis.体液生物标志物在阿尔茨海默病诊断中的作用。
Diagnostics (Basel). 2020 May 20;10(5):326. doi: 10.3390/diagnostics10050326.
8
Evaluation of cerebrospinal fluid phosphorylated tau as a biomarker in the differential diagnosis of Alzheimer's disease and vascular dementia.评估脑脊液磷酸化 tau 作为阿尔茨海默病和血管性痴呆鉴别诊断的生物标志物。
CNS Neurosci Ther. 2018 Aug;24(8):734-740. doi: 10.1111/cns.12814. Epub 2018 Feb 17.
9
Glypican-2 levels in cerebrospinal fluid predict the status of adult hippocampal neurogenesis.脑脊液中 GPC-2 水平可预测成人海马神经发生状态。
Sci Rep. 2017 Apr 25;7:46543. doi: 10.1038/srep46543.
10
High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease.脑脊液中高tau蛋白水平可预测阿尔茨海默病患者入住养老院的情况及疾病快速进展。
Alzheimers Res Ther. 2016 Jun 6;8(1):22. doi: 10.1186/s13195-016-0191-0.